41,592 Shares in National Health Investors, Inc. $NHI Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

Key Points

• Mitsubishi UFJ Asset Management purchased 41,592 shares of National Health Investors, valued at approximately $3.17 million, giving it a 0.09% stake. Institutional investors collectively own 62.51% of NHI.
• National Health Investors reported quarterly EPS of $1.19 on revenue of $121.32 million, with revenue up 1.6% year over year. The company maintained 2026 EPS guidance of $4.74–$4.79.
• NHI declared a quarterly dividend of $0.92, equivalent to $3.68 annually and a 5.0% yield. Analysts have a consensus “Moderate Buy” rating with an average price target of $83.86, above the reported $73.59 share price.

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 41,592 shares of the real estate investment trust's stock, valued at approximately $3,172,000. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.09% of National Health Investors as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new stake in shares of National Health Investors during the 4th quarter worth approximately $27,000. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock worth $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors during the 4th quarter worth $33,000. Advisory Services Network LLC bought a new stake in shares of National Health Investors in the 3rd quarter valued at about $65,000. Finally, Triumph Capital Management acquired a new stake in National Health Investors in the third quarter valued at approximately $66,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the acquisition, the director directly owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of National Health Investors stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company's stock, valued at approximately $9,177,473.44. This represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company's stock.

National Health Investors Stock Down 0.4%

NHI stock opened at $73.59 on Friday. National Health Investors, Inc. has a one year low of $67.94 and a one year high of $91.38. The firm's 50 day moving average price is $75.48 and its 200-day moving average price is $79.10. The firm has a market cap of $3.61 billion, a PE ratio of 21.27, a PEG ratio of 3.39 and a beta of 0.51. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm had revenue of $121.32 million during the quarter. During the same period in the previous year, the business posted $1.22 earnings per share. The firm's revenue for the quarter was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities research analysts anticipate that National Health Investors, Inc. will post 4.77 EPS for the current year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors's payout ratio is currently 106.36%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on NHI shares. Truist Financial lowered their price target on National Health Investors from $89.00 to $81.00 and set a "buy" rating for the company in a report on Friday, June 12th. BMO Capital Markets cut their price target on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a research report on Monday, June 15th. Wells Fargo & Company cut their target price on shares of National Health Investors from $84.00 to $79.00 and set an "equal weight" rating for the company in a report on Monday, June 1st. Zacks Research cut National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Finally, Weiss Ratings downgraded shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Moderate Buy" and an average price target of $83.86.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source